Half-year report · HY
9265.TEDINET S100XEU8
Period2025-06-01 → 2025-11-30
Filed2026-01-14
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 44
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥30.6bn | 2025-06-01 → 2025-11-30 | Cons. | Net sales |
| Revenue | ¥64.5bn | 2024-06-01 → 2025-05-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥31.4bn | 2024-06-01 → 2024-11-30 | Cons. | Net sales |
| Operating income | ¥216m | 2025-06-01 → 2025-11-30 | Cons. | Operating income |
| Operating income | ¥522m | 2024-06-01 → 2024-11-30 | Cons. | Operating income |
| Ordinary income | ¥297m | 2025-06-01 → 2025-11-30 | Cons. | Ordinary income |
| Ordinary income | ¥909m | 2024-06-01 → 2025-05-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥552m | 2024-06-01 → 2024-11-30 | Cons. | Ordinary income |
| Profit before tax | ¥295m | 2025-06-01 → 2025-11-30 | Cons. | Income before income taxes |
| Profit before tax | ¥586m | 2024-06-01 → 2024-11-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥134m | 2025-06-01 → 2025-11-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥616m | 2024-06-01 → 2025-05-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥338m | 2024-06-01 → 2024-11-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥133m | 2025-06-01 → 2025-11-30 | Cons. | Profit loss |
| Net income | ¥337m | 2024-06-01 → 2024-11-30 | Cons. | Profit loss |
| Total assets | ¥26.0bn | at 2025-11-30 | Cons. | Assets |
| Total assets | ¥27.5bn | at 2025-05-31 | Cons. | Assets |
| Total assets | ¥26.4bn | at 2024-11-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥17.0bn | at 2025-11-30 | Cons. | Liabilities |
| Total liabilities | ¥18.6bn | at 2025-05-31 | Cons. | Liabilities |
| Net assets / equity | ¥8.9bn | at 2025-11-30 | Cons. | Net assets |
| Net assets / equity | ¥9.0bn | at 2025-05-31 | Cons. | Net assets |
| Net assets / equity | ¥8.7bn | at 2024-11-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥3.3bn | at 2025-11-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥5.7bn | at 2025-05-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥3.3bn | at 2025-11-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥5.7bn | at 2025-05-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥4.4bn | at 2024-11-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥5.3bn | at 2024-05-31v | Cons. | Cash and cash equivalents |
| Operating cash flow | −¥1.4bn | 2025-06-01 → 2025-11-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥617m | 2024-06-01 → 2025-05-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | −¥633m | 2024-06-01 → 2024-11-30 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥615m | 2025-06-01 → 2025-11-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | ¥19m | 2024-06-01 → 2025-05-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | ¥19m | 2024-06-01 → 2024-11-30 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | −¥337m | 2025-06-01 → 2025-11-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥240m | 2024-06-01 → 2025-05-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥239m | 2024-06-01 → 2024-11-30 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥53.28 | 2025-06-01 → 2025-11-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥249.79 | 2024-06-01 → 2025-05-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥136.8 | 2024-06-01 → 2024-11-30 | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 34.3% | at 2025-11-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 32.6% | at 2025-05-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 32.9% | at 2024-11-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 35
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | revenue | 2025-06-01 → 2025-11-30 | ¥0 |
| Reconciling Itemsreconciling | revenue intersegment | 2025-06-01 → 2025-11-30 | ¥0 |
| Reconciling Itemsreconciling | segment profit | 2025-06-01 → 2025-11-30 | −¥510m |
| Medical Equipment Manufacturing And Salesreportable segment | revenue | 2025-06-01 → 2025-11-30 | ¥104m |
| Medical Equipment Manufacturing And Salesreportable segment | revenue external | 2025-06-01 → 2025-11-30 | ¥104m |
| Medical Equipment Manufacturing And Salesreportable segment | revenue intersegment | 2025-06-01 → 2025-11-30 | ¥0 |
| Medical Equipment Manufacturing And Salesreportable segment | segment profit | 2025-06-01 → 2025-11-30 | −¥111m |
| Medical Equipment Salesreportable segment | revenue | 2025-06-01 → 2025-11-30 | ¥30.5bn |
| Medical Equipment Salesreportable segment | revenue external | 2025-06-01 → 2025-11-30 | ¥30.5bn |
| Medical Equipment Salesreportable segment | segment profit | 2025-06-01 → 2025-11-30 | ¥834m |
| Medical Mallreportable segment | revenue | 2025-06-01 → 2025-11-30 | ¥36m |
| Medical Mallreportable segment | revenue external | 2025-06-01 → 2025-11-30 | ¥36m |
| Medical Mallreportable segment | segment profit | 2025-06-01 → 2025-11-30 | ¥4m |
| —segment total | revenue | 2025-06-01 → 2025-11-30 | ¥30.6bn |
| —segment total | revenue external | 2025-06-01 → 2025-11-30 | ¥30.6bn |
| —segment total | revenue intersegment | 2025-06-01 → 2025-11-30 | ¥0 |
| —segment total | segment profit | 2025-06-01 → 2025-11-30 | ¥727m |
| Reconciling Itemsreconciling | revenue | 2024-06-01 → 2024-11-30 | ¥0 |
| Reconciling Itemsreconciling | revenue intersegment | 2024-06-01 → 2024-11-30 | ¥0 |
| Reconciling Itemsreconciling | segment profit | 2024-06-01 → 2024-11-30 | −¥519m |
| Medical Equipment Manufacturing And Salesreportable segment | revenue | 2024-06-01 → 2024-11-30 | ¥113m |
| Medical Equipment Manufacturing And Salesreportable segment | revenue external | 2024-06-01 → 2024-11-30 | ¥112m |
| Medical Equipment Manufacturing And Salesreportable segment | revenue intersegment | 2024-06-01 → 2024-11-30 | ¥0 |
| Medical Equipment Manufacturing And Salesreportable segment | segment profit | 2024-06-01 → 2024-11-30 | −¥82m |
| Medical Equipment Salesreportable segment | revenue | 2024-06-01 → 2024-11-30 | ¥31.2bn |
| Medical Equipment Salesreportable segment | revenue external | 2024-06-01 → 2024-11-30 | ¥31.2bn |
| Medical Equipment Salesreportable segment | revenue intersegment | 2024-06-01 → 2024-11-30 | ¥0 |
| Medical Equipment Salesreportable segment | segment profit | 2024-06-01 → 2024-11-30 | ¥1.1bn |
| Medical Mallreportable segment | revenue | 2024-06-01 → 2024-11-30 | ¥35m |
| Medical Mallreportable segment | revenue external | 2024-06-01 → 2024-11-30 | ¥35m |
| Medical Mallreportable segment | segment profit | 2024-06-01 → 2024-11-30 | ¥0 |
| —segment total | revenue | 2024-06-01 → 2024-11-30 | ¥31.4bn |
| —segment total | revenue external | 2024-06-01 → 2024-11-30 | ¥31.4bn |
| —segment total | revenue intersegment | 2024-06-01 → 2024-11-30 | ¥0 |
| —segment total | segment profit | 2024-06-01 → 2024-11-30 | ¥1.0bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 487
| Item | Context | Value | Unit |
|---|---|---|---|
| Purchase of property plant and equipment inv cf | Prior1InterimDuration | -316000000 | JPY |
| Purchase of property plant and equipment inv cf | InterimDuration | -593000000 | JPY |
| Purchase of intangible assets inv cf | Prior1InterimDuration | -1000000 | JPY |
| Purchase of intangible assets inv cf | InterimDuration | -25000000 | JPY |
| Purchase of investment securities inv cf | Prior1InterimDuration | -2000000 | JPY |
| Purchase of investment securities inv cf | InterimDuration | -2000000 | JPY |
| Proceeds from purchase of investments in subsidiaries resulting in change in scope of consolidation inv cf | Prior1InterimDuration | 339000000 | JPY |
| Proceeds from purchase of investments in subsidiaries resulting in change in scope of consolidation inv cf | InterimDuration | － | JPY |
| Payments for sales of investments in subsidiaries resulting in change in scope of consolidation inv cf | Prior1InterimDuration | － | JPY |
| Payments for sales of investments in subsidiaries resulting in change in scope of consolidation inv cf | InterimDuration | -4000000 | JPY |
| Other net inv cf | Prior1InterimDuration | 0 | JPY |
| Other net inv cf | InterimDuration | 11000000 | JPY |
| Net cash provided by used in investment activities | Prior1InterimDuration | 19000000 | JPY |
| Net cash provided by used in investment activities | InterimDuration | -615000000 | JPY |
| Purchase of treasury stock fin cf | Prior1InterimDuration | -65000000 | JPY |
| Purchase of treasury stock fin cf | InterimDuration | -152000000 | JPY |
| Cash dividends paid fin cf | Prior1InterimDuration | -173000000 | JPY |
| Cash dividends paid fin cf | InterimDuration | -185000000 | JPY |
| Net cash provided by used in financing activities | Prior1InterimDuration | -239000000 | JPY |
| Net cash provided by used in financing activities | InterimDuration | -337000000 | JPY |
| Net increase decrease in cash and cash equivalents | Prior1InterimDuration | -853000000 | JPY |
| Net increase decrease in cash and cash equivalents | InterimDuration | -2391000000 | JPY |
| Cash and cash equivalents | Prior2YearInstant | 5300000000 | JPY |
| Cash and cash equivalents | Prior1YearInstant | 5698000000 | JPY |
| Cash and cash equivalents | Prior1InterimInstant | 4447000000 | JPY |
| Cash and cash equivalents | InterimInstant | 3306000000 | JPY |
| Salaries and allowances sga | Prior1InterimDuration | 1826000000 | JPY |
| Salaries and allowances sga | InterimDuration | 1901000000 | JPY |
| Provision for bonuses sga | Prior1InterimDuration | 188000000 | JPY |
| Provision for bonuses sga | InterimDuration | 216000000 | JPY |
| Retirement benefit expenses sga | Prior1InterimDuration | 55000000 | JPY |
| Retirement benefit expenses sga | InterimDuration | 28000000 | JPY |
| Revenues from external customers | Prior1InterimDuration_jpcrp040300-ssr_E33393-000MedicalEquipmentSalesReportableSegmentsMember | 31214000000 | JPY |
| Revenues from external customers | Prior1InterimDuration_jpcrp040300-ssr_E33393-000MedicalEquipmentManufacturingAndSalesReportableSegmentMember | 112000000 | JPY |
| Revenues from external customers | Prior1InterimDuration_jpcrp040300-ssr_E33393-000MedicalMallReportableSegmentsMember | 35000000 | JPY |
| Revenues from external customers | Prior1InterimDuration_ReportableSegmentsMember | 31362000000 | JPY |
| Revenues from external customers | Prior1InterimDuration_ReconcilingItemsMember | － | JPY |
| Revenues from external customers | Prior1InterimDuration | 31362000000 | JPY |
| Transactions with other segments | Prior1InterimDuration_jpcrp040300-ssr_E33393-000MedicalEquipmentSalesReportableSegmentsMember | 0 | JPY |
| Transactions with other segments | Prior1InterimDuration_jpcrp040300-ssr_E33393-000MedicalEquipmentManufacturingAndSalesReportableSegmentMember | 0 | JPY |
| Transactions with other segments | Prior1InterimDuration_jpcrp040300-ssr_E33393-000MedicalMallReportableSegmentsMember | － | JPY |
| Transactions with other segments | Prior1InterimDuration_ReportableSegmentsMember | 0 | JPY |
| Transactions with other segments | Prior1InterimDuration_ReconcilingItemsMember | -0 | JPY |
| Transactions with other segments | Prior1InterimDuration | － | JPY |
| Net sales | Prior1InterimDuration_jpcrp040300-ssr_E33393-000MedicalEquipmentSalesReportableSegmentsMember | 31214000000 | JPY |
| Net sales | Prior1InterimDuration_jpcrp040300-ssr_E33393-000MedicalEquipmentManufacturingAndSalesReportableSegmentMember | 113000000 | JPY |
| Net sales | Prior1InterimDuration_jpcrp040300-ssr_E33393-000MedicalMallReportableSegmentsMember | 35000000 | JPY |
| Net sales | Prior1InterimDuration_ReportableSegmentsMember | 31363000000 | JPY |
| Net sales | Prior1InterimDuration_ReconcilingItemsMember | -0 | JPY |
| Net sales | Prior1InterimDuration | 31362000000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |